Yan Xin

Yan Xin

Auto-generated profile, based on publicly available information

Yan Xin

Laboratory of Gastrointestinal Onco-Pathology, Cancer Institute and General Surgery Institute, The First Affiliated Hospital of China Medical University, Shenyang, China

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2019 in Cancer Communications
Verified
Journal Article
Open access
PDF file
FWFeng Wang
Feng Wang
SLShen Lin
Shen Lin
JLJin Li
Jin Li
ZZZhi‐Wei Zhou
Zhi‐Wei Zhou
HLHan Liang
Han Liang
RXRui-Hua Xu
Rui-Hua Xu
China is one of the countries with the highest incidence of gastric cancer. There are differences in epidemiological characteristics, clinicopathological features, tumor biological characteristics, treatment patterns, and drug selection between gastric cancer patients from the Eastern and Western countries. Non‐Chinese guidelines cannot specifically reflect the diagnosis and treatment characteristics for the Chinese gastric cancer patients. The Chinese Society of Clinical Oncology (CSCO) arranged for a panel of senior experts specializing in all sub‐specialties of gastric cancer to compile, discuss, and revise the guidelines on the diagnosis and treatment of gastric cancer based on the findings of evidence‐based medicine in China and abroad. By referring to the opinions of industry experts, taking into account of regional differences, giving full consideration to the accessibility of diagnosis and treatment resources, these experts have conducted experts’ consensus judgement on relevant evidence and made various grades of recommendations for the clinical diagnosis and treatment of gastric cancer to reflect the value of cancer treatment and meeting health economic indexes. This guideline uses tables and is complemented by explanatory and descriptive notes covering the diagnosis, comprehensive treatment, and follow‐up visits for gastric cancer.

13 February 2018 in Journal of Hematology & Oncology
Verified
Journal Article
Open access
PDF file
MZMiaoci Zhang
Miaoci Zhang
YXYan Xin
Yan Xin
In recent years, circular RNAs (circRNAs) have attracted considerable attention because they play a significant role in many fields of cancer biology. Additionally, it has become increasingly clear that circRNAs have the potential to make contributions to the successful application of individualized cancer medicine. This brief review introduces circRNAs by describing their potential as a biomarker and therapeutic target and discussing the possible strategies to target them. This review also presents the challenges that are encountered by circRNAs for their definitive entry into clinical practice. Clearly, our understanding of circRNAs helps to add a new dimension to the molecular structure of cancer and will provide many new opportunities for cancer treatment.

7 November 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
DSDan Sun
Dan Sun
XLXiaoting Li
Xiaoting Li
YHYingjian He
Yingjian He
WLWenhui Li
Wenhui Li
YWYing Wang
Ying Wang
YXYan Xin
Yan Xin
YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo

1 January 2009 in World Journal of Gastroenterology
Verified
Journal Article
Closed access
CDChun-Li Da
Chun-Li Da
YXYan Xin
Yan Xin
JZJing Zhao
Jing Zhao
XLXiang-Dong Luo
Xiang-Dong Luo
AIM: To analyze the differences and relevance of Yes-associated protein (YAP) and survivin, and to explore the correlation and significance of their expression in gastric carcinoma and precancerous lesions.

19 March 2014 in Pathology and Oncology Research
Verified
Journal Article
Closed access
PDF file
XHXiaobin Hu
Xiaobin Hu
YXYan Xin
Yan Xin
YXYuping Xiao
Yuping Xiao
JZJing Zhao
Jing Zhao

1 January 2003 in World Journal of Gastroenterology
Verified
Journal Article
Open access
ZHZheng Hua-Chuan
Zheng Hua-Chuan
JSJin-Min Sun
Jin-Min Sun
ZWZheng-Li Wei
Zheng-Li Wei
XYXue-Fei Yang
Xue-Fei Yang
YZYin-Chang Zhang
Yin-Chang Zhang
YXYan Xin
Yan Xin
Expression of Fas ligand and Caspase-3 contributes to formation of immune escape in gastric cancer